首页> 外文期刊>Anti-cancer agents in medicinal chemistry >Design, Synthesis, Cytotoxic Activity and Apoptosis-inducing Action of Novel Cinnoline Derivatives as Anticancer Agents
【24h】

Design, Synthesis, Cytotoxic Activity and Apoptosis-inducing Action of Novel Cinnoline Derivatives as Anticancer Agents

机译:新型辣椒碱衍生物作为抗癌剂的设计,合成,细胞毒性活性和凋亡诱导作用

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: Tyrosine kinases and topoisomerase I are common target enzymes for the majority of the anticanceragents. In contrast to quinazolines and quinolines, kinase inhibitors and topoisomerase inhibitors incorporatingcinnoline scaffold are relatively infrequent. Thus the aim of this work was to replace the former scaffoldswith the latter one. Eighteen novel cinnoline derivatives were designed, synthesized and characterizedusing both microanalytical and spectral data.Methods: The cytotoxic activity of the new compounds was screened in vitro against both human breast cancercells and normal breast cells.Results: The enzymatic inhibition activity of promising candidates against both epidermal growth factor receptortyrosine kinase and topoisomerase I was accomplished.Conclusions: Cell cycle profiles were observed at IC50 doses of representative biologically active compounds.Compound 7 represented a new scaffold incorporating triazepinocinnoline ring system and showed outstandingcytotoxic activity against MCF-7 (0.049 μM), tyrosine kinase inhibition (0.22 μM), apoptosis percentage and thehighest selectivity index.
机译:目的:酪氨酸激酶和拓扑异构酶I是大多数抗癌剂的常见目标酶。与喹唑啉和喹啉素形成对比,激酶抑制剂和含有琥珀啉支架的激酶抑制剂和拓扑异构酶抑制剂相对罕见。因此,这项工作的目的是取代后者的前脚手架。设计,合成和表征了18个新型的肉碱衍生物。方法:将新化合物的细胞毒性活性对人乳腺癌和正常乳房细胞进行筛选。结果:对两者都有前景候选者的酶促抑制活性完成表皮生长因子丙蛋白激酶和拓扑异构酶I。结论:在IC50代表生物活性化合物中观察到细胞周期曲线.Pound 7代表了一种新的支架,掺入三氮杂萘啉环系统,并显示出对MCF-7(0.049μm)的优异毒性活性,酪氨酸激酶抑制(0.22μm),凋亡率和最高选择性指数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号